I25
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with documented stable coronary artery disease. Written informed consent and willigness to give a sample of 20 ml venous blood.
Exclusion criteria
Exclusion criteria: - Active infection or fever - Pregnancy or breastfeeding - Chronic inflammatory disease (e.g. M. Crohn, Rheumatoid Arthritis) - HIV infection or active hepatitis - Neoplastic disease without documented complete remission within the past 5 years - Apoplectic insult within the past 3 months - Impaired renal function (creatinine >2.5 mg/dl) at the time of treatment - Relevant liver disease (GOT >2 ULN, or spontaneous INR >1.5) - Mental retardation - Any condition that per investigator?s judgment increases the patient?s risk or excludes adequate collection of study data - Participation in another clinical trial within the past 30 days
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of microRNAs in progenitor cells of patients with coronary artery disease and in healthy controls. | — |
Countries
Germany
Contacts
Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe-University Frankfurt;Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe-University Frankfurt